On Nov. 17, 2021, GlaxoSmithKline and Vir Biotechnology announced U.S. government contracts totalling approximately $1 billion (USD) to…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHopeﾙ Genetic Health program aimed…
On Nov. 16, 2021, the University of Oxfordﾒs and AstraZeneca announced that two billion doses of the ChAdOx1…
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…
On Nov. 12, 2021, Regeneron announced that the European Commission (EC) had approved the casirivimab and imdevimab antibody…
On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
On Nov. 11, 2021, Roche announced that the European Medicines Agencyﾒs (EMA) Committee for Medicinal Products for Human…
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyﾒs Phase 2 clinical trial of Brilacidin…
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
On Nov. 9, 2021, Swedish announced a $20 million personal bequest from the late philanthropist Paul G. Allen,…
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
On Nov. 9, 2021, Novan announced promising preclinical safety results with berdazimer sodium in a 14-day GLP repeat…
On Nov. 9, 2021, Inovio Pharma announced that the U.S. Food and Drug Administration (FDA) provided authorization to…
On Nov. 9, 2021, Howard Hughes Medical Institute announced the program, named Codetta, can read the genome sequence…
On Nov. 8, 2021, Regeneron announced that the European Commission had approved the casirivimab and imdevimab antibody cocktail,…